ADDICTION POTENTIAL OF ZOLPIDEM: EVIDENCE FROM PRECLINICAL STUDIES

被引:0
|
作者
Rowlett, J. [1 ]
Berro, L. [1 ]
机构
[1] Univ Mississippi, Med Ctr, Psychiat & Human Behav, Jackson, MS 39216 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:288 / 288
页数:1
相关论文
共 50 条
  • [1] Potential addiction pharmacotherapies: Insights from preclinical research
    Lawrence, Andrew J.
    Lubman, Dan
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 : A48 - A48
  • [2] Potential role of creatine as an anticonvulsant agent: evidence from preclinical studies
    Alraddadi, Eman A. A.
    Khojah, Abdulrahman M. M.
    Alamri, Faisal F. F.
    Kecheck, Husun K. K.
    Altaf, Wid F. F.
    Khouqeer, Yousef
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [3] Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment : Evidence from Preclinical Studies
    Mostofa, A. G. M.
    Hossain, Md Kamal
    Basak, Debasish
    Bin Sayeed, Muhammad Shahdaat
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [4] Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies
    Chandra Prakash
    Jyoti Tyagi
    Shyam Sunder Rabidas
    Vijay Kumar
    Deepak Sharma
    NeuroMolecular Medicine, 2023, 25 : 163 - 178
  • [5] Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies
    Prakash, Chandra
    Tyagi, Jyoti
    Rabidas, Shyam Sunder
    Kumar, Vijay
    Sharma, Deepak
    NEUROMOLECULAR MEDICINE, 2023, 25 (02) : 163 - 178
  • [6] The role of metabotropic glutamate receptors in addiction: Evidence from preclinical models
    Duncan, Jhodie R.
    Lawrence, Andrew J.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 100 (04) : 811 - 824
  • [7] TAAR1 AGONISTS AS POTENTIAL ANTI-ADDICTION CANDIDATES: PRECLINICAL EVIDENCE
    Li, Jun-Xu
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i4 - i5
  • [8] EVIDENCE FROM PRECLINICAL STUDIES: THE EFFECT OF THE MUSCARINIC M1 RECEPTOR ANTAGONIST BIPERIDEN ON ALCOHOL ADDICTION
    Palombo, P.
    Engi, S. A.
    Yokoyama, T. S.
    Santos, P. C. J. L.
    Bezerra, A. G.
    Galduroz, J. C.
    Cruz, F. C.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 215A - 215A
  • [9] Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease
    Dihoum, Adel
    Rena, Graham
    Pearson, Ewan R.
    Lang, Chim C.
    Mordi, Ify R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 291 - 299
  • [10] Epidemiological evidence for a low abuse potential of zolpidem
    Soyka, M
    Bottlender, R
    Möller, HJ
    PHARMACOPSYCHIATRY, 2000, 33 (04) : 138 - 141